Lemerle J, Tournade M F, Sarrazin D, Gerard-Marchant R, Rodary C, Fekete C, Voute P A
Arch Fr Pediatr. 1981 May;38(5):329-34.
Study of 724 cases of Wilm's tumor treated between 1952 and 1980 at the Gustave-Roussy Institute, according to 5 successive therapeutic protocols with or without chemotherapy (Actinomycin alone or Actinomycin and Vincristine). Recovery rates change from 44 to over 90% during this period. Improvement of survival was first obtained by the efficient treatment of metastases, then by preventing their development with systematic chemotherapy with Actinomycin and Vincristine. Rate of survival without relapse changed from 38 to 71 and 86%. Thus, the decrease in the number of patent metastases subjected to heavy treatments responsible for severe respiratory and orthopedic sequelae improved the quality of survival of these children.
对1952年至1980年间在古斯塔夫 - 鲁西研究所接受治疗的724例威尔姆斯瘤病例进行研究,依据5种连续的治疗方案,采用或不采用化疗(单独使用放线菌素或放线菌素与长春新碱联合使用)。在此期间,缓解率从44%变化至90%以上。生存率的提高首先是通过对转移灶的有效治疗,然后是通过使用放线菌素和长春新碱进行系统性化疗来预防转移灶的发生。无复发生存率从38%变化至71%和86%。因此,接受导致严重呼吸和骨科后遗症的重度治疗的有明显转移灶的病例数量减少,改善了这些儿童的生存质量。